1 / 32

Is Genomics the Cure for Disparities?

Is Genomics the Cure for Disparities?. Francis S. Collins, M.D., Ph.D. National Leadership Summit to Eliminate Racial and Ethnic Disparities in Health January 10, 2006. What is the nature of human genetic variation?. www.hapmap.org. Genetic Variation in Africa. Spreading around the World.

viveca
Télécharger la présentation

Is Genomics the Cure for Disparities?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Is Genomics theCure for Disparities? Francis S. Collins, M.D., Ph.D. National Leadership Summit to Eliminate Racial and Ethnic Disparities in Health January 10, 2006

  2. What is the nature of human genetic variation?

  3. www.hapmap.org

  4. Genetic Variation in Africa

  5. Spreading around the World

  6. What is the relationship between genetic variation and race?

  7. December 18, 2002 Genes expose race only as a sham The idea of race was not reflected in a person’s genes, Brazilian researchers said yesterday, confirming what scientists have long said – that race has no meaning genetically.

  8. June 4, 2003 No trace of race; Genome Sequencing Project proves nothing biological separates peoples

  9. October 1, 2002 For Sale: A DNA Test To Measure Racial Mix A company in Sarasota, Fla., is offering a DNA test that it says will measure customers’ racial ancestry and their ancestral proportions if they are of a mixed race.

  10. www.ancestrybydna.com

  11. July 28, 2003 Race Plays Role in New Drug Trials; Treatment by Genetic Origin, Ethnicity Divides Medical Profession

  12. What does “race”mean anyway?

  13. What we know about genetics and race • We are all 99.9% identical at the DNA level • That still leaves millions of differences • Most of these variants were present in our common ancestors • But the frequency of a particular variant will often differ between populations, as a result of • “Genetic drift” • Founder effects • Selection • New mutations

  14. What we know about genetics and race (cont.) • Such differences may be used to make statistical predictions of geographic origins, but in general there will be considerable overlap between groups • The history of human populations is more of a trellis than a tree

  15. Africa Out of Africa The “Wisteria Vine’ view of human evolution and diversification © 1999 Kenneth K Kidd, Yale University

  16. What we know about genetics and race (cont.) • Except in cases of extreme geographic isolation, the genetic boundaries around population groups will be blurry and imprecise • When differences in prevalence of illness are observed between groups, this could be due to: • Genetic differences • Dietary, cultural, environmental, socioeconomic factors • A mixture of both

  17. ANCENTRAL GEOGRAPHIC ORIGINS ENVIRONMENTAL EXPOSURES SELF-IDENTIFIED RACE OR ETHNICITY VARIANTS IN DISEASE GENES EDUCATION GENOME VARIATION ACCESS TO HEALTH CARE CULTURE SOCIOECONOMIC STATUS STRESS HEALTH OR DISEASE

  18. The Case of BiDil® • BiDil® is a combination of two generic drugs, isosorbide dinitrate and hydralazine. • It acts as a nitric oxide enhancer. • Nitric oxide dilates blood vessels, reducing the amount of resistance the heart has to pump against.

  19. The Case of BiDil® (cont.) • BiDil® was originally tested in clinical trials for heart failure in the 1980s and 1990s. • It showed possible benefit, but the FDA ruled in 1997 that the results were unconvincing. • A retrospective analysis suggested that benefit was greatest in African American patients. • Patent was filed on the use of this drug for African Americans, and PTO approved it.

  20. The Case of BiDil® (cont.) • BiDil® was then tested for benefits in treating heart failure in 1100 African American men and women • Trial was supported by the Association of Black Cardiologists and the National Medical Association

  21. Survival Curve NEJM 351:2049-2057, 2004

  22. The Case of BiDil® (cont.) • FDA approved BiDil® for the treatment of congestive heart failure in the summer of 2005 • Indications: “BiDil is indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status.” • A mixed blessing?

  23. Summary • “Race” is a term which carries a great deal of baggage; the use of more precise definitions would assist our societal dialogue • Much is being learned about worldwide genetic variation that informs us of our shared heritage • Neither of these statements is correct: • Race has absolutely no biological basis • Genetics allows us to draw sharp boundaries between groups • To understand and prevent health disparities, we should seek more proximate causes, not depend on the muddy proxies of race and ethnicity

  24. Is Genomics theCure for Disparities? • Probably not • But in some instances, genomics may identify heritable factors that play a role, though almost always in concert with environmental factors • We need more data

More Related